| P50 | author | Yibin Kang | Q88721106 |
| P2093 | author name string | Martin M Matzuk | |
| | Diana Monsivais | |
| | Jia Peng | |
| P2860 | cites work | TGF-beta signaling by Smad proteins | Q22253317 |
| | p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest | Q24319021 |
| | Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 |
| | TGFbeta signaling in growth control, cancer, and heritable disorders | Q28142605 |
| | TGFbeta in Cancer | Q28288866 |
| | Integrated genomic characterization of endometrial carcinoma | Q28289962 |
| | Requirement of Bmpr1a for Müllerian duct regression during male sexual development | Q28504908 |
| | FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features | Q28731816 |
| | Patterns of somatic mutation in human cancer genomes | Q29547841 |
| | DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 | Q29616726 |
| | Uterine activin receptor-like kinase 5 is crucial for blastocyst implantation and placental development. | Q30360302 |
| | Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function | Q30430202 |
| | Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. | Q30439551 |
| | Three-dimensional microCT imaging of mouse development from early post-implantation to early postnatal stages | Q30847031 |
| | Positive and negative regulation of TGF-beta signaling | Q33855168 |
| | Role of progesterone in endometrial cancer | Q34095034 |
| | Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. | Q34393919 |
| | Stromal-to-epithelial transition during postpartum endometrial regeneration | Q34411987 |
| | Role of uterine contraction in regeneration of the murine postpartum endometrium. | Q50652896 |
| | Generation of Bmpr/Alk3 conditional knockout mice. | Q52123530 |
| | Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. | Q52546101 |
| | The role of TGF-β/SMAD4 signaling in cancer. | Q52688883 |
| | Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer. | Q54655999 |
| | Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins | Q57027655 |
| | Endometrial cancer | Q63199203 |
| | Uterine double-conditional inactivation of and in mice causes endometrial dysregulation, infertility, and uterine cancer | Q64235119 |
| | Endocrine Control of the Timing of Endometrial Sensitivity to a Decidual Stimulus | Q70430735 |
| | Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies | Q73722520 |
| | Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck | Q73934582 |
| | Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer | Q74256297 |
| | PAX8 expression in uterine adenocarcinomas and mesonephric proliferations | Q87485106 |
| | Two pathogenetic types of endometrial carcinoma | Q34713298 |
| | Transforming growth factor beta--a mediator of immune deviation in seminal plasma | Q34973790 |
| | High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability | Q35275603 |
| | Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function | Q35787724 |
| | Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling | Q36107307 |
| | Alterations in components of the TGF-beta superfamily signaling pathways in human cancer | Q36323395 |
| | Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes | Q36447819 |
| | Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives | Q36981305 |
| | Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation | Q37140110 |
| | Evidence from a mouse model that epithelial cell migration and mesenchymal-epithelial transition contribute to rapid restoration of uterine tissue integrity during menstruation | Q37505694 |
| | Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice | Q37680979 |
| | Cre-mediated recombination in cell lineages that express the progesterone receptor | Q38521008 |
| | Seminal fluid and fertility in women | Q38916733 |
| | The TGF-β Family in the Reproductive Tract | Q38963328 |
| | Cancer Statistics, 2017. | Q39038674 |
| | SMAD Signaling Is Required for Structural Integrity of the Female Reproductive Tract and Uterine Function During Early Pregnancy in Mice. | Q41132068 |
| | A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. | Q41706409 |
| | Transforming growth factor beta and the endometrium | Q41724601 |
| | A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma | Q42120115 |
| | Expression of TGF-beta type I and II receptors in normal and cancerous human endometrium. | Q44126430 |
| | Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. | Q45345231 |
| | Smad3 mutant mice develop metastatic colorectal cancer | Q45345236 |
| | International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013. | Q46324858 |
| | Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification | Q46764265 |
| | Role of high molecular weight seminal vesicle proteins in eliciting the uterine inflammatory response to semen in mice | Q47328310 |
| | Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice. | Q48210146 |
| | The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain | Q48615076 |
| | Frequency of Smad gene mutations in human cancers. | Q48676822 |
| | Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers. | Q50335584 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | knockout mouse | Q1364740 |
| | endometrial carcinoma | Q18555222 |
| | metastatic endometrial carcinoma | Q19001077 |
| P304 | page(s) | 3883-3892 | |
| P577 | publication date | 2019-02-26 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Activin-like kinase 5 (ALK5) inactivation in the mouse uterus results in metastatic endometrial carcinoma | |
| P478 | volume | 116 | |